Desq Long
Sign in

Company

Kymera Therapeutics, Inc.

KYMR · CIK 0001815442

SEC FORM 4
$139,699.95

Kymera Therapeutics, Inc. (KYMR)

Sale of 1,209 shares at $115.55 per share.

Reporting Person Adams Brian · Officer Title Chief Legal Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001193125-26-383874 · filed 2026-09-04 · View filing →

SEC FORM 4
$353,350.25

Kymera Therapeutics, Inc. (KYMR)

Sale of 3,025 shares at $116.81 per share.

Reporting Person Adams Brian · Officer Title Chief Legal Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001193125-26-383874 · filed 2026-09-04 · View filing →

SEC FORM 4
$251,247.09

Kymera Therapeutics, Inc. (KYMR)

Sale of 2,137 shares at $117.57 per share.

Reporting Person Adams Brian · Officer Title Chief Legal Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001193125-26-383874 · filed 2026-09-04 · View filing →